Pharmex Logo (EUIPO, 04/28/2016)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark Pharmex was filed as Figurative mark on 04/28/2016 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/28/2017.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Bubbles, frothy masses, speech bubbles #Other backgrounds divided into two, three or four #One letter #Letter 'P' #Green #Blue
| Trademark form | Figurative mark |
| File reference | 015384175 |
| Application date | April 28, 2016 |
| Publication date | May 12, 2016 |
| Entry date | April 28, 2017 |
| Expiration date | April 28, 2026 |
Trademark owner
Place de la Gare 2
1950 Sion
CH
1950 Sion
CH
Trademark representatives
5bis avenue du Pré Closet
74940 ANNECY
FR
Objection / Complaint
07/19/2016: Likelihood of confusion
Unfair advantage /detriment to distinctiveness or repute
Applicant
NSE Products, Inc.
goods and services
3
Soap; Perfumery, essential oils, cosmetics, hair lotions; Dentifrices
5
Pharmaceutical and veterinary preparations, namely, Preparations for the treatment of allergies, hay fever, travel sickness, heart failure, skin problems, the treatment of dermatitis, skin pigmentation diseases, the treatment of fever blisters, the treatment and prevention of dry skin, eczema, acne, the treatment of atopy, the treatment of sunburn, skin irritation, fissures, cracks, insect bites, minor wounds, skin rashes, warts, for the treatment of gynaecological disorders, the treatment of hot flushes and functional problems relating to menopause, and for the treatment of liver diseases, digestive system disorders, intestinal diseases, gastroenterological diseases, diseases relating to intestinal flora imbalance, for the treatment of haemorrhoid attacks, diarrhoea, for the treatment of urological infections, urinary functional disorders, for the treatment of central nervous system diseases and symptoms, namely anxiety, spasms, sleep disorders, nervosity, irritability, irritation, apprehension, emotional palpitations, of epileptic origin, for use in the field of oncology, the treatment of eye strain, eye irritation, the treatment of ear, nose and throat diseases, the treatment of influenza-like diseases, voice loss, sore throat, hoarseness, laryngitis, rhinitis, cold, cough, for the treatment of teething symptoms in infants, namely gum pain, restlessness and irritability, for the treatment of symptoms relating to abdominal colic pain in babies, namely abdominal pain, cramps, spasms and gas, for the treatment of flu symptoms in children, for the treatment of irritability and light sleep in children, for the treatment of seasonal and environmental allergy symptoms in children, namely sneezing, runny nose, watery eyes, itching and sore throat, for the treatment of joint, muscle, tendon and ligament disorders and diseases, for the treatment of joint and muscle pain, muscular fatigue, cramps, fatigue, for the treatment of toothache, for the treatment of oral infections, for trauma use, for the treatment of bruises, bumps, soreness, pain, fever, headaches; Pharmaceutical preparations for the treatment of cardiovascular, hematological, bone, respiratory, central nervous system diseases, namely anxiety, spasms, sleep disorders, nervosity, irritability, irritation, apprehension, emotional palpitations, of epileptic origin, endocrinological, circulatory, hormonal and diabetic disorders, anti-inflammatory agents, immunity system disorders and related illnesses, metabolic disorders, anti-infectives, eye disorders and for use in oncology; Diagnostic preparations and/or Diagnostic reagents for clinical or medical laboratory use; Sanitary preparations for medical purposes, Namely disinfectants and Soaps; Food for babies; Adhesive tapes for medical purposes; Materials for (dressings); None of the aforesaid goods being related to neurological, neuropathic, neurodegenerative, neuromuscular diseases, peripheral nervous system or central nervous system diseases and/or disorders, with the sole exception of the central nervous system, the treatment of diseases and symptoms of anxiety, spasms, sleep disorders, nervosity, irritability, irritation, apprehension, emotional palpitations, or of epileptic origin
10
Surgical, medical, dental and veterinary apparatus and instruments; Artificial limbs, eyes and teeth; Orthopedic articles; Suture materials
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| July 11, 2023 | Transfer / Change of address, Published | ||
| July 6, 2023 | Transfer / Change of address, Published | ||
| June 13, 2023 | Change Representative, Published | ||
| September 29, 2022 | Correction, Published | ||
| February 25, 2022 | RAW: Trade mark - Partial Surrender, Published | ||
| November 24, 2021 | Decision on opposition, Published | ||
| September 8, 2021 | Change Representative, Published | ||
| October 17, 2019 | Change Representative, Published | ||
| October 15, 2019 | Change Representative, Published | ||
| May 17, 2019 | Change Representative, Published | ||
| April 25, 2019 | appealed, Published | ||
| September 2, 2016 | Change Representative, Published |
ID: 11015384175